🇺🇸 FDA
Patent

US 7772219

Methods of hormonal treatment utilizing extended cycle contraceptive regimens

granted A61KA61K31/565A61K31/57

Quick answer

US patent 7772219 (Methods of hormonal treatment utilizing extended cycle contraceptive regimens) held by TEVA WOMEN'S HEALTH, INC. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA WOMEN'S HEALTH, INC.
Grant date
Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/565, A61K31/57, A61P, A61P15/00